Not finding it? Sign in to also search OpenAlex live.
-
ESD bei flächigem Tumor im ileorektalen Pouch nach Kolektomie bei Colitis ulcerosa: Organerhaltende Therapieoption2025 Zeitschrift für Gastroenterologie conference-paper Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Oscar Cahyadi, Karim Hamesch, C. Torres Reyes, M. Tophof, Daniel Robert Quast, Alanna Ebigbo
0citations -
Effectiveness and safety of tofacitinib for ulcerative colitis: two‐year results of the ICC Registry2022 Alimentary Pharmacology & Therapeutics article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Tessa Straatmijer, Fiona D M van Schaik, Alexander G L Bodelier, Marijn Caroline Visschedijk, Annemarie Charlotte de Vries, Cyriel Y. Ponsioen, +13 more
28citations -
O21 Long-term efficacy and safety of filgotinib 200 mg in ulcerative colitis: 5-year interim data from SELECTIONLTE2025 Oral Presentations conference-paper Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Ian D. Arnott, Brian G. Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, David Laharie, Severine A.R.A. Vermeire, +9 more
0citations -
Soluble mucosal addressin cell adhesion molecule 1 is a biomarker for pediatric ulcerative colitis2026 Molecular and Cellular Pediatrics article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Moritz Muschaweck, Christian Gutbier, Gernot Sellge, Angeliki Pappa, Tobias G. Wenzl, Karim Hamesch, +2 more
0citations -
Faecal Microbiota Transplantation Engraftment After Budesonide or Placebo in Patients With Active Ulcerative Colitis Using Pre-selected Donors: A Randomized Pilot Study2024 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access cited by 1 patent
Emilie van Lingen, Sam Nooij, Elisabeth M. Terveer, Emily M. Crossette, Amanda Prince, Shakti K. Bhattarai, +10 more
25citations -
Dynamics of Gut Microbiota After Fecal Microbiota Transplantation in Ulcerative Colitis: Success Linked to Control of Prevotellaceae2024 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Susanne Pinto, Dominika Šajbenová, Elisa Benincà, Sam Nooij, Elisabeth M. Terveer, Josbert J. Keller, +3 more
20citations -
Filgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from the SELECTION Trial2023 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Brian G. Feagan, Laurent Peyrin‐Biroulet, Severine A.R.A. Vermeire, Margaux Faes, Alessandra Faria Oortwijn, +3 more
18citations -
Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study2022 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Edward V. Loftus, Severine A.R.A. Vermeire, Brian G. Feagan, Franck‐Olivier Le Brun, Alessandra Faria Oortwijn, Ulrik Moerch, +2 more
12citations -
Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial2023 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Iris Dotan, Brian G. Feagan, Virginia Taliadouros, Alessandra Faria Oortwijn, Christine Rudolph, Angela de Haas, +4 more
10citations -
OP07 Exploring disease control by combining clinical, biological, and health-related quality of life remission with endoscopic improvements among Ulcerative Colitis patients treated with filgotinib: A post-hoc analysis from the SELECTION trial2022 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Brian G. Feagan, Laurent Peyrin‐Biroulet, Severine A.R.A. Vermeire, Margaux Faes, Alessandra Faria Oortwijn, +3 more
5citations -
P491 Efficacy and safety outcomes of long-term treatment with filgotinib 200 mg among patients with Ulcerative Colitis: An interim analysis of SELECTIONLTE2022 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
B G Feagan Senior Scientific Officer, Katsuyoshi Matsuoka, Gerhard Rogler, Margaux Faes, Alessandra Faria Oortwijn, C Rudolph, +2 more
5citations -
DOP37 Efficacy and safety of filgotinib in patients with Ulcerative Colitis stratified by age: Post hoc analysis of the phase 2b/3 SELECTION and SELECTIONLTE studies2022 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Edward V. Loftus, Christian Maaser, Silvio Danese, C Rudolph, Rob Jongen, +2 more
5citations -
P293 Insights from patients with Ulcerative Colitis on disease burden: Findings from a real-world survey in Europe2022 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
AL Hart, Alessandra Faria Oortwijn, Mona Aeysha Khalid, Fritha Hennessy, Hannah Knight, Haridarshan Patel, +1 more
4citations -
P393 Effect of filgotinib on anaemia in patients with Ulcerative Colitis in SELECTION2023 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Roberta Loveikyte, Alessandra Faria Oortwijn, B Eskens, C Jamoul, K. Muller, A van der Meulen-de Jong
3citations -
P517 Re-treatment with filgotinib in patients with Ulcerative Colitis following treatment interruption: Analysis of the SELECTION and SELECTIONLTE studies2022 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Severine A.R.A. Vermeire, Brian G. Feagan, Laurent Peyrin‐Biroulet, Alessandra Faria Oortwijn, Margaux Faes, Gerhard Rogler
2citations -
OP25 Efficacy of filgotinib in patients with Ulcerative Colitis by line of therapy in the phase 2b/3 SELECTION trial2021 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Laurent Peyrin‐Biroulet, Iris Dotan, Toshifumi Hibi∥, Virginia Taliadouros, Alessandra Faria Oortwijn, Sally Zhao, +3 more
2citations -
P690 Prolonged benefit of filgotinib in patients with Ulcerative Colitis in SELECTION2023 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
David Laharie, A Sturm, Taku Kobayashi, Takayuki Matsumoto, Alessandra Faria Oortwijn, C Jamoul, +2 more
1citations -
P551 Benefit–risk trade-offs and patient preferences for therapy selection in Ulcerative Colitis: a multi-country preference study2024 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Javier P. Gisbert, Stefan Schreiber, Corey Allan Siegel, Fernando Magro, Anna Jus, Chiara L. Whichello, +4 more
1citations -
P772 Comprehensive disease control in patients with Ulcerative Colitis: refinement of a multi-component endpoint using data from the filgotinib SELECTION trial2024 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Stefan Schreiber, Brian G. Feagan, Severine A.R.A. Vermeire, Silvio Danese, Veerle Vyncke, Margaux Faes, +2 more
0citations -
P0118 Plasma proteomic signatures relate to disease course and intestinal immune responses, uncovering immunotypes among Crohn’s Disease and Ulcerative Colitis patients2026 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
B Calado, Maud Heredia, Mohammed Charrout, Renz C. W. Klomberg, Daniëlle M.H. Barendregt, D H Hulleman-van Haaften, +6 more
0citations -
DOP45 Predicting late responders to filgotinib in patients with moderately to severely active Ulcerative Colitis: A post hoc analysis of SELECTION and SELECTIONLTE2023 Journal of Crohn s and Colitis article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Kana Matsuoka, Mark Löwenberg, Mathurin Fuméry, Yoshie Takatori, Y Fujitani, Alessandra Faria Oortwijn, +3 more
0citations -
P319 Characteristics of filgotinib-treated patients with Ulcerative Colitis who achieve sustained corticosteroid-free remission: Post hoc analysis of the phase 2b/3 SELECTION study2023 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Teruaki Kobayashi, AU Dignass, Xavier Roblin, Y Fujitani, Alessandra Faria Oortwijn, C Jamoul, +1 more
0citations -
P736 Factors associated with partial Mayo Clinic Score over time in patients with Ulcerative Colitis treated with filgotinib in the phase 2b/3 SELECTION trial2023 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Laurent Peyrin‐Biroulet, E Louis, Tadakazu Hisamatsu, C Jamoul, Eva Santermans, K Harris, +2 more
0citations -
P225 Mucosal transcriptomic profiles associated with clinical response in patients with Ulcerative Colitis receiving filgotinib2024 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access cited by 1 patent
Fernando Magro, Brian G. Feagan, Gerhard Rogler, Laurent Peyrin‐Biroulet, Yasmina Bauer, Lise Cougnaud, +4 more
0citations